| Affiliation: | 1. Chemical Biology and Therapeutics Science, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA;2. Department of Medicine, Harvard Medical School, Boston, MA 02115, USA;3. Divisions of Renal Medicine and Engineering, Brigham and Women’s Hospital, Boston, MA 02115, USA;4. Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA;1. Chinese Academy of Sciences (CAS) Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, 11 Zhongguancun Beiyitiao, Beijing 100190, China;2. Sino-Danish Center for Education and Research, Sino-Danish College, University of the Chinese Academy of Sciences, Beijing 100049, China;1. Division of Nephrology and Hypertension and Section of Mineral Metabolism, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA;1. Australian Institute for Biotechnology and Nanomaterials, University of Queensland, St Lucia, Australia;2. School of Biotechnology and Biomolecular Biosciences, and University of New South Wales (UNSW) RNA Institute, UNSW Sydney, Sydney, Australia;1. Translational Liver Research, Department of Medical Cell BioPhysics, Faculty of Science and Technology, Technical Medical Center, University of Twente, Enschede 7500 AE, The Netherlands;2. Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Rheinisch-Westfälische Technische Hochschule (RWTH) University Hospital Aachen, Aachen 52074, Germany;3. Centre for Biomedical Engineering (CBME), Indian Institute of Technology (IIT), Hauz Khas, New Delhi 110016, India |
